Surgical management of acute pancreatitis in Italy: lessons from aprospective multicentre study

L'articolo è uno studio multicentrico tra i cui autori è presente G.Benassai (membro del ProInf-AISP Study Grp). http://www.ncbi.nlm.nih.gov/pubmed/20961367 RE: Missing Author Name Scopus nlinfo@elsevier.com; Dear Prof. Giacomo Benassai, Thank you very much for your detailed explanation. You have made the issue perfectly clear to me. Please be informed that I have escalated the issue to our Content Department for investigation and they will rectify the issue accordingly. As soon as I receive an answer, I am happy to contact you back. If I, or one of my colleagues, can assist you with another matter please do let us know. Kind Regards, Jeroen Hulsmann E-Helpdesk EMEA Coordinator Regional Sales Office - EMEA Elsevier B.V. [THREAD ID:1-1J7YLX6] -----Original Message----- From: gbenassa@unina.it Sent: 12/09/2012 14:52:37 To: nlinfo@elsevier.com Subject: Re: FW: Author's name correction Distinct Mr. Hulsmann Thank you for the sollicit interest about my query.This question it's very important for my career evaluation and also for the University 's department in which i belong. I have participated as a researcher in the 3 papers reported in my previous email,all of them were multicentric,so as of definition they involve diverse Institutions and Authors.In the list of Authors reported,members of the ProINF-AISP study group are citated under the voice "the members of the ProInf-AISP Study Group" who obviously do not correspond to a single unit.The single members of the citated group,amongst them the writer,are citated singularly on the last page's appendix ("G. Mosella, G. Benassai Policlinico Universitario Federico II") Napoli. The non citation of this partecipation of the Naples University Federico II comes with a problem regarding the financiation of the department,and also a discrimination on the evaluation of my personal profile as a researcher about the calculation of the citations in the H index. Furthermore in other circumstances i was citated as a participant in group studies of multicenter works,such as "Imipenem/cilastatina (1,5gr/die) versus meropenem (3,0gr/die) in pazienti con infezioni intra-addominali:risultati di uno studio clinico multicentrico,randomizzato,prospettico" publicated on Scandinavian Journal of Infectious Diseases 29:503-508,1997.I believe you have an original PDF file of this work and not a copy,therefore i result citated on scopus as a participant of the group study "Gruppo di studio Italiano" Thank you for your courtesy and interest,given the importance of the query. Trustfully yours, Prof. Giacomo Benassai Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, Registration No. 33156677 (The Netherlands) OBJECTIVE: This study aimed to evaluate the surgical treatment of acute pancreatitis in Italy and to assess compliance with international guidelines. METHODS: A series of 1173 patients in 56 hospitals were prospectively enrolled and their data analysed. RESULTS: Twenty-nine patients with severe pancreatitis underwent surgical intervention. Necrosectomy was performed in 26 patients, associated with postoperative lavage in 70% of cases. A feeding jejunostomy was added in 37% of cases. Mortality was 21%. Of the patients with mild pancreatitis, 714 patients with a biliary aetiology were evaluated. Prophylactic treatment of relapses was carried out in 212 patients (36%) by cholecystectomy and in 161 using a laparoscopic approach. Preoperative endoscopic retrograde cholangiopancreatography was associated with cholecystectomy in 83 patients (39%). Forty-seven patients (22%) were treated at a second admission, with a median delay of 31 days from the onset of pancreatitis. Eighteen patients with severe pancreatitis underwent cholecystectomy 37.9 days after the first admission. There were no deaths. DISCUSSION: The results indicate poor compliance with published guidelines. In severe pancreatitis, early surgical intervention is frequently performed and enteral feeding is seldom used. Only a small number of patients with mild biliary pancreatitis undergo definitive treatment (i.e. cholecystectomy) within 4 weeks of the onset of pancreatitis.